Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the Perugia General Practitioner Study

Internal and Emergency Medicine

Volumn 10, Issue 5, 2015, Pages 595-601

  Salvatori, Valentina ^a   Becattini, Cecilia ^a   Laureti, Stefano ^b   Baglioni, Gregorio ^b   Germini, Fabrizio ^b   Grilli, Piero ^b   Guercini, Francesco ^a   Filippucci, Esmeralda ^a   Agnelli, Giancarlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Società Italiana Medicina Generale   (Italy)

Author keywords

Atrial fibrillation; Excessive supraventricular ectopic activity; Holter monitoring; Silent atrial fibrillation

Indexed keywords

AGE; AGED; AMBULATORY ELECTROCARDIOGRAPHY; ATRIAL FIBRILLATION; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREVALENCE;

EID: 84937978785     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1241-5     Document Type: Article

References (34)

1. Ryder KM, Benjamin EJ (1999) Epidemiology and significance of atrial fibrillation. Am J Cardiol 84:131R–138R
2. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. JAMA 271:840–844
3. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM, CHS Collaborative Research Group (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236–241
4. Tsang TS, Petty GW, Barnes ME, O’Fallon WM, Bailey KR, Wiebers DO, Sicks JD, Christianson TJH, Seward JB, Gersh BJ (2003) The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota. J Am Coll Cardiol 42:93–100
5. Friberg J, Scharling H, Gadsboll N, Jensen GB (2003) Sex-specific increase in the prevalence of atrial fibrillation (the Copenhagen city heart study). Am J Cardiol 92:1419–1423
6. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM (2009) Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 119:2146–2152
7. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983–988
8. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age, distribution, and gender of patients with atrial fibrillation. Arch Intern Med 13:469–473
9. Paciaroni M, Agnelli G, Caso V, Venti M, Milia P, Silvestrelli G, Parnetti L, Biagini S (2005) Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost 3:1218–1223
10. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 333:175–179
11. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
12. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Frederick R, Rickles FR, Ralph Shabetai R, Deykin D, Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (1992) Warfarin in the prevention of stroke associated with non rheumatic atrial fibrillation. N Engl J Med 327:1404–1412
13. Savelieva I, Camm AJ (2000) Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 4:369–382
14. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, ASSERT Investigators (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129
15. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee GL, Lamas GA, MOST Investigators (2003) Atrial high rate episodes detected by pacemaker diagnostic predict death and stroke report of the atrial diagnostics ancillary study of the Mode Selection Trial (MOST). Circulation 107:1614–1619
16. Botto G, Padelletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G (2009) Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 20:241–248
17. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) Focus update of the ESC guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 14:1385–1413
18. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429
19. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89:224–227
20. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A (2010) Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121:1904–1911
21. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50(22):2173–2195
22. Somerville S, Somerville J, Croft P, Lewis M (2000) Atrial fibrillation: a comparison of methods to identify cases in general practice. Br J Gen Pract 50:727–729
23. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, Raftery JP, Bryan S, Davies M, Lip GY, Allan TF (2007) Screening vs. routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. Br Med J 335:383
24. Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G (2005). A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 9:iii–iv, ix–x, 1–74
25. Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M (2007) Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38:2935–2940
26. Manina G, Agnelli G, Becattini C, Zingarini G, Paciaroni M (2014) 96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med 9:65–67
27. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ (2013) Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 80:1546–1550
28. Jons C, Raatikainen P, Gang UJ, Huikuri HV, Joergensen RM, Johannesen A, Dixen U, Messier M, McNitt S, Thomsen PE, Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group (2010) Autonomic dysfunction and new-onset atrial fibrillation in patients with left ventricular systolic dysfunction after acute myocardial infarction: a CARISMA substudy. J Cardiovasc Electrophysiol 21:983–990
29. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O’Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M, EMBRACE Investigators and Coordinators (2014) Atrial fibrillation in patients with cryptogenic stoke. N Engl J Med 370(26):2467–2477
30. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J, CRYSTAL AF Investigators (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486
31. Wu MA, Scannella E, Gruppo di Autoformazione Metodologica (2014) Atrial fibrillation detection after cryptogenic stroke. Intern Emerg Med 9(8):887–888
32. Flaker Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators (2005) Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149:657–663
33. Go A, Hylek E, Phillips K, Chang Y, Henault L, Selby J, Singer D (2001) Prevalence of diagnosed atrial fibrilation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285:2370–2375
34. Heeringa J, van der Kuip DA, Hofman A, Kors JA, Van Herpen G, Stricker BHC, Stijnen T, Lip GYH, Witteman JCM (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953